By Wendy Van Sickle
Columbus, Ohio, April 4 – UBS AG, London Branch priced $645,000 of trigger autocallable contingent yield notes due April 1, 2021 linked to the lesser performing of the Technology Select Sector SPDR fund and the SPDR S&P Biotech ETF, according to a 424B2 filing with the Securities and Exchange Commission.
The notes will pay a contingent quarterly coupon at an annual rate of 8.22% if each ETF closes at or above its coupon barrier level, 65% of its initial level, on the observation date for that quarter.
The notes will be called at par if each ETF closes at or above its initial level on any quarterly observation date other than the final one.
The payout at maturity will be par unless either ETF finishes below the 65% downside threshold, in which case investors will lose 1% for each 1% decline of the worse performing ETF.
UBS Financial Services Inc. and UBS Investment Bank are the agents.
Issuer: | UBS AG, London Branch
|
Issue: | Trigger autocallable contingent yield notes
|
Underlying ETFs: | Technology Select Sector SPDR fund and SPDR S&P Biotech ETF
|
Amount: | $645,000
|
Maturity: | April 1, 2021
|
Coupon: | 8.22%, payable quarterly if each ETF closes at or above coupon barrier on observation date
|
Price: | Par
|
Call: | At par plus contingent coupon if both ETFs close at or above initial levels on any quarterly observation date other than the final one
|
Payout at maturity: | Par unless either ETF closes below downside threshold, in which case 1% loss for each 1% decline of worse performing ETF
|
Initial levels: | $72.98 for Technology, $87.76 for Biotech
|
Coupon barriers: | $47.44 for Technology, $57.04 for Biotech; 65% of initial levels
|
Downside thresholds: | $47.44 for Technology, $57.04 for Biotech; 65% of initial levels
|
Pricing date: | March 27
|
Settlement date: | March 29
|
Agents: | UBS Financial Services Inc. and UBS Investment Bank
|
Fees: | 2.35%
|
Cusip: | 90270KYT0
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.